3 not yet recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Not yet recruiting 3 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Biotroy Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies BT02 - Relapsed or Refractory Hematologic Malignancies, Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Biotroy Therapeutics | 116 | 2025-10-01 | 2025-09-17 |
| A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma BT02 - Advanced Melanoma, Advanced Solid Tumor | Phase 1 | Not yet recruiting | Biotroy Therapeutics | 58 | 2025-08-08 | 2025-08-06 |
| A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer BT02 - Advanced Malignant Solid Tumor, Advanced Lung Cancer | Phase 1 | Not yet recruiting | Biotroy Therapeutics | 58 | 2025-08-01 | 2025-08-07 |
Carcinoma, Non-Small-Cell Lung (1) · Hematologic Neoplasms (1) · Leukemia (1) · Lymphoma (1) · Multiple Myeloma (1) · Recurrence (1) · Small Cell Lung Carcinoma (1)
Jun Guo, MD (1) · Shun Lu, MD (1) · Ying Wang, MD (1)